A notable shift is emerging in regenerative medicine. The U.S. Food and Drug Administration is beginning to reconsider and restore access to a number of previously restricted peptides. This marks an important Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Semax Research Peptide Information Peptpedia Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Everything You Need to Know About the FDA Peptide Ban